Heads UP – Episode 126: Migraine Medication Failures

Have you had a migraine medication fail you? Or have multiple migraine medications failed you? How did it make you feel? In this episode of Heads UP Lindsay Weitzel, Ph.D. talks to Melissa Geraghty Psy.D. about how this makes us…

Read More

neurology live

Evaluating Chronic Migraine Medication Overuse Strategies

Neurology Live April 30, 2022 Marco Meglio Vincent Martin, MD, president of the National Headache Foundation, discussed the MOTS trial, a non-inferiority study aimed at understanding treatment strategies with preventives for chronic migraine. Vincent Martin, MD The Medication Overuse Treatment…

Read More

Episode-118-Medication-Overuse

Heads UP – Episode 118: Medication Overuse Treatment Strategy Trial for Migraine and Headache

Heads UP – Episode 118: Medication Overuse Treatment Strategy Trial -The idea of medication overuse and medication overuse headache can seem almost contradictory at times. It can seem like the very medicines we were instructed to take at the onset…

Read More

treating-migraine-with-infusions-116

Heads UP – Episode 116: Treating Migraine With Infusions

Heads UP – Episode 116: Treating Migraine With Infusions – In this week’s episode of Heads UP Lindsay Weitzel, Ph.D. discusses infusions with Dr. Merle Diamond, MD. What infusions are used to break a migraine cycle and why? What medicines…

Read More

watch-from-home

Don’t Lose Hope: Learn About New Treatments for Migraine at the 2022 Migraine World Summit

Whether you’re new to migraine disease or have struggled with it for years, there can be moments of despair. Will this medication work? What am I doing wrong? How can I control this? Can I get back my life? In…

Read More

Add your name graphic

Allow Migraine Patients and Primary Care Providers to Set Care Plans – NOT INSURERS

Add your name to the NHF’s petition if you agree that insurance companies should adopt care models that are patient-centric, where the clinician, in collaboration with the patient, is the primary decision-maker and selects a treatment that addresses the patient’s…

Read More

Access to care cover

Heads UP – Episode 112: Access to Care

  For too long, migraine patients have been treated differently than others with medical issues as it relates to access to prescription medications. The National Headache Foundation advocates that payers adopt care models that are patient-centric, where the clinician, in…

Read More

NHF Calls on Congress and Federal Agencies to Conduct Oversight Of Current Care Models for Migraine Patients graphic

NHF Calls on Congress and Federal Agencies to Conduct Oversight Of Current Care Models for Migraine Patients

Chicago, Ill. (Feb. 3, 2022) – Tom Dabertin, Chief Executive Officer/Executive Director of the National Headache Foundation (NHF) is calling on members of Congress and regulatory agencies to conduct oversight of health insurance payers for uneven treatment of migraine patients. On…

Read More

National Headache Foundation Position Statement on the Treatment of Migraine and Access to Care graphic

National Headache Foundation Position Statement on the Treatment of Migraine and Access to Care

January 19, 2022   For more than 52 years, the National Headache Foundation (NHF) has been the voice for more than 40 million American adults with migraine. For too long, migraine patients have been treated differently than others with medical…

Read More

National Headache Foundation Position Statement on the Treatment of Migraine and Access to Care graphic

NHF Challenges Current Care Models for Migraine Patients

Older Prescription Drugs in a Stepwise Approach Needs Health Insurance Overhaul Chicago, Ill. (Jan. 19, 2022) – The National Headache Foundation issued a statement challenging health insurance payers for uneven treatment of migraine patients, arguing “current care models have not…

Read More

nasal-spray

Heads UP – Episode 109: DATA Alert on Intranasal Zavegepant

New Data Alert on the Up-and-Coming Migraine Medication: Intranasal Zavegepant. While not yet approved for release, intranasal zavegepant has shown promise in some interesting and unique data points in the relief of acute migraine. What is zavegepant and what will…

Read More

pills-pink-background

Heads UP – Episode 103: Atogepant and Migraine

Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard questions: Can we take…

Read More